Organovo Holdings Inc
VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with … Read more
Organovo Holdings Inc (ONVO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: -4.948x
Based on the latest financial reports, Organovo Holdings Inc (ONVO) has a cash flow conversion efficiency ratio of -4.948x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.80 Million) by net assets ($364.00K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Organovo Holdings Inc - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Organovo Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Organovo Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Organovo Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Golden Tobacco Limited
NSE:GOLDENTOBC
|
0.032x |
|
Rani Zim Shopping Centers
TA:RANI
|
0.016x |
|
Panca Mitra Multiperdana Tbk PT
JK:PMMP
|
-0.258x |
|
Permsin Steel Works Public Company Limited
BK:PERM
|
0.167x |
|
Goff Corp
PINK:WNFT
|
-0.002x |
|
MASTEC (MY8.SG)
STU:MY8
|
0.098x |
|
ClearStream Energy Services Inc
PINK:NWPIF
|
0.188x |
|
Indosterling Technomedia Tbk
JK:TECH
|
-0.019x |
Annual Cash Flow Conversion Efficiency for Organovo Holdings Inc (2011–2024)
The table below shows the annual cash flow conversion efficiency of Organovo Holdings Inc from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-03-31 | $3.60 Million | $-14.65 Million | -4.069x | -402.71% |
| 2023-03-31 | $15.33 Million | $-12.41 Million | -0.809x | -189.28% |
| 2022-03-31 | $30.21 Million | $-8.45 Million | -0.280x | +17.68% |
| 2021-03-31 | $39.20 Million | $-13.32 Million | -0.340x | +39.17% |
| 2020-03-31 | $26.63 Million | $-14.88 Million | -0.559x | +0.45% |
| 2019-03-31 | $36.30 Million | $-20.38 Million | -0.561x | +13.27% |
| 2018-03-31 | $44.59 Million | $-28.86 Million | -0.647x | -38.30% |
| 2017-03-31 | $62.36 Million | $-29.18 Million | -0.468x | +0.91% |
| 2016-03-31 | $62.18 Million | $-29.37 Million | -0.472x | -17.34% |
| 2015-03-31 | $48.70 Million | $-19.60 Million | -0.403x | -24.90% |
| 2014-03-31 | $48.28 Million | $-15.56 Million | -0.322x | -117.63% |
| 2013-03-31 | $-5.30 Million | $-9.69 Million | 1.828x | -89.28% |
| 2012-03-31 | $-6.42K | $-109.42K | 17.052x | 0.00% |
| 2011-03-31 | $-6.42K | $-109.42K | 17.052x | -- |